Neuca

Neuca Days Payable Outstanding

The Days Payable Outstanding (DPO) of Neuca (NEU.WA) as of Oct 21, 2026 is 119.95. In the previous year, Days Payable Outstanding (DPO) was 105.84 — a change of 13.33% (higher).

Days Payable Outstanding

119.95

YoY

13.33%

Last updated:

Days Payable Outstanding (DPO) of Neuca is 2025 119.95 . Days Payable Outstanding (DPO) of Neuca was 2024 105.84 . It decreases by 13.33% higher compared to the previous year.

The Neuca Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2018
115.79 PLN
Jan 1, 2019
113.25 PLN
Jan 1, 2020
107.34 PLN
Jan 1, 2021
106.99 PLN
Jan 1, 2022
113.15 PLN
Jan 1, 2023
113.23 PLN
Jan 1, 2024
105.84 PLN
Jan 1, 2025
119.95 PLN
The Neuca Days Payable Outstanding history
YEARDays Payable OutstandingYoY
119.95+13.33%
105.84-6.52%
113.23+0.07%
113.15+5.76%
106.99-0.33%
107.34-5.21%
113.25-2.20%
115.79+2.04%
113.47+5.12%
107.95-2.67%
110.91-0.76%
111.76—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neuca Stock analysis

What does Neuca do? NEUCA SA generates revenue through the wholesale distribution of pharmaceutical products to pharmacies, leveraging its extensive network in the health market. The company also produces and sells its own branded drugs, supplements, and cosmetics, while offering clinical trials, telemedicine services, and IT solutions tailored for healthcare providers. Its e-commerce platform further supports the healthcare industry by enabling digital transactions for medical products and services. The primary buyers include pharmacies, healthcare institutions, and consumers seeking health-related products through online channels. NEUCA SA's business model integrates multiple revenue streams within the health sector, with a focus on both physical and digital distribution. The firm's own-brand products, such as pharmaceuticals and cosmetics, are sold directly to end-users and retail partners, while its IT solutions and telemedicine services target healthcare organizations. Clinical trials represent another key segment, attracting partnerships with research institutions and pharmaceutical firms. The company's operational scope spans from production to distribution, ensuring a comprehensive approach to healthcare market needs. The company's revenue is driven by its diversified portfolio, including drug distribution, branded product sales, and specialized services like telemedicine and clinical trials. Pharmacies remain the core customer segment for its wholesale operations, while e-commerce and IT solutions cater to a broader audience of healthcare providers and consumers. NEUCA SA's strategic positioning in the health market allows it to capitalize on multiple growth areas without relying on a single revenue source. Neuca is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neuca stock

Days Payable Outstanding (DPO) of Neuca is 119.95 in 2025.

Days Payable Outstanding (DPO) of Neuca changed from 105.84 to 119.95, representing a 13.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Neuca since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Neuca with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Neuca

All Key Metrics — Neuca